PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Symptom | C0239946|hepatic fibrosis |
| Sentences | 39 |
| PubMedID- 23505555 | The i148m variant represents a susceptibility factor for hepatic fibrosis in patients with chronic liver diseases , but has only been attributed to parenchymal liver disease. |
| PubMedID- 24367211 | Transient elastography (fibroscan™, echosens, paris, france) is a novel method for the evaluation of hepatic fibrosis in patients with chronic liver diseases.117–119 mri has superior soft-tissue contrast resolution, lacks ionizing radiation, and has the possibility of performing functional and metabolic imaging sequences, which are particularly advantageous for serial examinations to monitor therapy response and the whole liver surveillance of hcc and hepatic dysplastic nodules. |
| PubMedID- 20875899 | Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. |
| PubMedID- 24843721 | In japan, serum type iv collagen 7s is now widely used for assessing the extent of hepatic fibrosis in patients with chronic liver disease, including nash22, because the test is covered by public health insurance, but there is little evidence of assessment of this parameter in nafld patients in western countries. |
| PubMedID- 25788200 | Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center. |
| PubMedID- 25923941 | Measurements of serum procollagen-iii peptide and m30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. |
| PubMedID- 22978413 | Our results suggest that curcumin may be useful for prevention of hepatic fibrosis in patients with advanced liver disease. |
| PubMedID- 22087126 | Several studies have suggested that the aspartate aminotransferases (ast) to platelet ratio index (apri) may be a useful noninvasive marker of hepatic fibrosis in patients with chronic liver disease . |
| PubMedID- 24976280 | Egy-score is a relatively new panel of biomarkers used for the assessment of the stage of hepatic fibrosis in patients with chronic liver diseases. |
| PubMedID- 24267865 | Background & aims: coffee has inverse relationships with both type 2 diabetes and hepatic fibrosis in patients with nonalcoholic fatty liver disease (nafld). |
| PubMedID- 26039496 | Furthermore, the ‘non-invasive’ diagnosis of hepatic fibrosis in patients with chronic liver disease has progressed significantly recently and have shown high diagnostic accuracy for significant fibrosis and liver cirrhosis. |
| PubMedID- 24834487 | Many studies have reported the use of this method in the assessment of hepatic tumors, hepatic fibrosis associated with chronic liver disease, treatment response following radiotherapy and chemotherapy, and hepatic perfusion changes after radiological or surgical interventions. |
| PubMedID- 24072087 | Several studies have suggested that the aspartate aminotransferase-to-platelet ratio index (apri) may be a useful noninvasive marker of hepatic fibrosis in patients with chronic liver disease (7,8,9,10). |
| PubMedID- 22087164 | Te (fibroscan) is a new sonography-based, noninvasive, and rapid method of diagnosing and quantifying hepatic fibrosis in patients with chronic liver diseases. |
| PubMedID- 25544873 | Third, obi may contribute to the progression of hepatic fibrosis in patients with chronic liver disease including hepatitis c. |
| PubMedID- 20658587 | Transient elastography (te) is a valuable noninvasive technique of measuring liver stiffness and a reliable tool for predicting hepatic fibrosis in patients with chronic liver disease. |
| PubMedID- 25612182 | Selection criteria: diagnostic cohort and diagnostic case-control study designs that assessed hepatic fibrosis in participants with alcoholic liver disease with transient elastography and liver biopsy, irrespective of language or publication status. |
| PubMedID- 24040957 | The critical role of nox in hepatic fibrogenesis provides a rationale to assess pharmacological nox inhibitors that treat hepatic fibrosis in patients with chronic liver disease. |
| PubMedID- 24558397 | All chronic liver diseases can lead to hepatic fibrosis and eventually liver failure. |
| PubMedID- 24064151 | Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease. |
| PubMedID- 22408151 | Development and evaluation of a nurse-led transient elastography service for the staging of hepatic fibrosis in patients with suspected chronic liver disease. |
| PubMedID- 22469726 | The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases. |
| PubMedID- 23538889 | Objectives: the objective of this study was to compare the diagnostic performance of magnetic resonance elastography (mre) and gadoxetate disodium-enhanced magnetic resonance imaging (mri) in the staging of hepatic fibrosis (hf) in patients with liver diseases. |
| PubMedID- 24779010 | hepatic fibrosis is usually associated with chronic liver diseases caused by infection, drugs, metabolic disorders, or autoimmune imbalances. |
| PubMedID- 21987293 | Coffee caffeine consumption (cc) is associated with reduced hepatic fibrosis in patients with chronic liver diseases, such as hepatitis c. |
| PubMedID- 22082207 | Liver stiffness can be measured by the novel method of transient elastography (fibroscan) and is closely associated with hepatic fibrosis in patients with chronic liver disease, but also is increased in patients with acute hepatitis, acute liver failure and cholestasis. |
| PubMedID- 22506126 | Transient elastography (te, fibroscan, echosens, france) is a noninvasive technique developed to assess hepatic fibrosis in patients with chronic liver diseases. |
| PubMedID- 22467259 | Fructose consumption predicts increased hepatic fibrosis in those with nonalcoholic fatty liver disease (nafld). |
| PubMedID- 24978903 | Tm6sf2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. |
| PubMedID- 22492469 | Purpose: we compared quantitative indices estimated by use of technetium-(99m) galactosyl human serum albumin ((99m)tc-gsa) single-photon emission computed tomography (spect)/computed tomography (ct) fused imaging and hepatic fibrosis in patients with chronic liver disease. |
| PubMedID- 26214688 | Hepatitis c virus (hcv) infection is the main cause of chronic liver disease, leading to progressive hepatic fibrosis and ultimately cirrhosis. |
| PubMedID- 26049712 | Diagnostic usefulness of fibrometer vcte for hepatic fibrosis in patients with nonalcoholic fatty liver disease. |
| PubMedID- 23959503 | Nonalcoholic fatty liver disease (nafld) may lead to hepatic fibrosis. |
| PubMedID- 20728571 | Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic fatty liver disease. |
| PubMedID- 21168695 | Background: hepatic fibrosis, an outcome of chronic liver diseases, is characterized by an accumulation of collagen, which is produced by activated human intrahepatic fibroblasts (hif). |
| PubMedID- 22957328 | Progressive hepatic fibrosis is a feature of almost all chronic liver diseases. |
| PubMedID- 22257449 | During the last years, transient elastography (fibroscan(r)) has been proposed for the assessment of hepatic fibrosis in patients with chronic liver disease, by measuring liver stiffness. |
| PubMedID- 23295601 | Objective: during the neonatal and infancy periods, some chronic liver diseases may lead to progressive hepatic fibrosis, which is a condition that can ultimately result in the loss of organ function and severe portal hypertension necessitating hepatic transplantation. |
| PubMedID- 26515640 | The enhancement of liver regeneration is also required for the success of pharmacological approaches that aim to reverse hepatic fibrosis due to chronic liver diseases6. |
Page: 1